IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company’s FDA discussions confirmed that relapse-free survival ...

These data demonstrate that results for INB-100 do not appear to be due to imbalances in patient selection criteria ... free remissions in high-risk or relapsed AML patients undergoing HSCT ...

The data, previously announced, reinforce INB-100’s potential to significantly reduce post-transplant relapse in high-risk acute myeloid leukemia (AML) patients, positioning this gamma-delta T ...

IN8bio (INAB) presented Phase 1 data on its allogeneic gamma-delta T cell therapy, INB-100, at the 2025 Transplantation & Cellular Therapy, ...

Annual Regulatory Oversight Report provides member firms with key insights and observations from its regulatory operations programs. The report covers fixtures such as financial crimes prevention, ...

The gambling industry is a high-stakes arena—not just for players but for money launderers exploiting its vulnerabilities.

Genomic Interrogation of Secondary-Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies,” published in the February 2025 issue of American Journal of Hematology by Senapati et ...

What April 2026’s requirement on agents to HMRC-register means if you're a limited company in the market for tax advice.

CrossFi, a prominent innovator in blockchain-based financial solutions, has announced the successful completion of a rigorous ...

Study authors discussed evidence from ongoing CHR-p research showing that SGM populations are at increased risk for developing psychosis.

Have you wondered how the new law for cryptos will be in the future? Warren Buffett has stated that you simply take your dip ...